Moreover, an in vitro study by Horibe et al. has reported that an anti-TPR peptide that blocks the interaction of HSP90 with the TPR domain of STIP1 is induces cell death in lung, renal, prostate, pancreatic, and gastric cancer cell lines [32]. Here, STIP1 is linked to gastric cancer.